Plasma Levels of MiR-29b and MiR-200b in Type 2 Diabetic Retinopathy

Overview

Journal J Cell Mol Med

Specialties Cell Biology
Molecular Biology

Date 2018 Nov 24

PMID 30467971

Citations 20

Authors

Maria Enoia Dantas da Costa E Silva

Evelise Regina Polina

Daisy Crispim

Renan Cesar Sbruzzi

Daniel Lavinsky

Felipe Mallmann

Nidiane Carla Martinelli

Luis Henrique Canani

Katia Goncalves Dos Santos

Affiliations

Soon will be listed here.

Abstract

MicroRNAs (miRNAs/miRs) are involved in the pathogenesis of diabetes mellitus and its chronic complications, and their circulating levels have emerged as potential biomarkers for the development and progression of diabetes. However, few studies have examined the expression of miRNAs in diabetic retinopathy (DR) in humans. This case-control study aimed to investigate whether the plasma levels of miR-29b and miR-200b are associated with DR in 186 South Brazilians with type 2 diabetes (91 without DR, 46 with non-proliferative DR and 49 with proliferative DR). We also included 20 healthy blood donors to determine the miRNA expression in the general population. Plasma levels of miR-29b and miR-200b were quantified by reverse transcription-quantitative polymerase chain reaction (RT-qPCR). Proliferative DR was inversely associated with plasma levels of miR-29b (unadjusted OR = 0.694, 95% CI: 0.535-0.900, P = 0.006) and miR-200b (unadjusted OR = 0.797, 95% CI: 0.637-0.997, P = 0.047). However, these associations were lost after controlling for demographic and clinical covariates. In addition, patients with type 2 diabetes had lower miR-200b levels than blood donors. Our findings reinforce the importance of addressing the role of circulating miRNAs, including miR-29 and miR-200b, in DR.

Citing Articles

The Association of Cell-Free LncH19 and miR-29b Expression with the PI3K/AKT/HIF-1/VEGF Pathway in Patients with Diabetic Nephropathy: In Silico Prediction and Clinical Validation.

Abd El-Fadeal N, Sultan B, AbdelMaogood A, Al Ageeli E, Mekhamer F, Rohayem S Curr Issues Mol Biol. 2025; 47(1).

PMID: 39852135 PMC: 11764133. DOI: 10.3390/cimb47010020.

12-HETE activates Müller glial cells: The potential role of GPR31 and miR-29.

Moustafa M, Khalil A, Darwish N, Zhang D, Tawfik A, Al-Shabrawey M Prostaglandins Other Lipid Mediat. 2023; 171:106805.

PMID: 38141777 PMC: 10939904. DOI: 10.1016/j.prostaglandins.2023.106805.

Microvesicle-associated and circulating microRNAs in diabetic dyslipidemia: miR-218, miR-132, miR-143, and miR-21, miR-122, miR-155 have biomarker potential.

Nemecz M, Stefan D, Comarita I, Constantin A, Tanko G, Guja C Cardiovasc Diabetol. 2023; 22(1):260.

PMID: 37749569 PMC: 10521428. DOI: 10.1186/s12933-023-01988-0.

Effect and mechanism of microRNAs on various diabetic wound local cells.

Li H, Jing S, Xu H J Diabetes. 2023; 15(11):955-967.

PMID: 37679063 PMC: 10667630. DOI: 10.1111/1753-0407.13474.

Prevalence of diabetic retinopathy in Brazil: a systematic review with meta-analysis.

Chagas T, Dos Reis M, Leivas G, Santos L, Gossenheimer A, Melo G Diabetol Metab Syndr. 2023; 15(1):34.

PMID: 36864478 PMC: 9979496. DOI: 10.1186/s13098-023-01003-2.

References

Priscakova P, Minarik G, Repiska V . Candidate gene studies of diabetic retinopathy in human. Mol Biol Rep. 2016; 43(12):1327-1345. PMC: 5102952. DOI: 10.1007/s11033-016-4075-y. View

Jiang Q, Zhao F, Liu X, Li R, Liu J . Effect of miR-200b on retinal endothelial cell function under high glucose environment. Int J Clin Exp Pathol. 2015; 8(9):10482-7. PMC: 4637573. View

Dantas da Costa E Silva M, Polina E, Crispim D, Sbruzzi R, Lavinsky D, Mallmann F . Plasma levels of miR-29b and miR-200b in type 2 diabetic retinopathy. J Cell Mol Med. 2018; 23(2):1280-1287. PMC: 6349208. DOI: 10.1111/jcmm.14030. View

Jiang Q, Lyu X, Yuan Y, Wang L . Plasma expression: an indicator for the severity of Type 2 diabetes with diabetic retinopathy. Biosci Rep. 2017; 37(2). PMC: 5469322. DOI: 10.1042/BSR20160589. View

Liang Y, Li J, Xiao H, He Y, Zhang L, Yan Y . Identification of stress-related microRNA biomarkers in type 2 diabetes mellitus: A systematic review and meta-analysis. J Diabetes. 2018; 12(9):633-644. DOI: 10.1111/1753-0407.12643. View

McClelland A, Kantharidis P . microRNA in the development of diabetic complications. Clin Sci (Lond). 2013; 126(2):95-110. DOI: 10.1042/CS20130079. View

Zou H, Wang Y, Gang Q, Zhang Y, Sun Y . Plasma level of miR-93 is associated with higher risk to develop type 2 diabetic retinopathy. Graefes Arch Clin Exp Ophthalmol. 2017; 255(6):1159-1166. DOI: 10.1007/s00417-017-3638-5. View

Levey A, Stevens L, Schmid C, Zhang Y, Castro 3rd A, Feldman H . A new equation to estimate glomerular filtration rate. Ann Intern Med. 2009; 150(9):604-12. PMC: 2763564. DOI: 10.7326/0003-4819-150-9-200905050-00006. View

Banerjee J, Nema V, Dhas Y, Mishra N . Role of MicroRNAs in Type 2 Diabetes and Associated Vascular Complications. Biochimie. 2017; 139:9-19. DOI: 10.1016/j.biochi.2017.05.007. View

10.

Zampetaki A, Kiechl S, Drozdov I, Willeit P, Mayr U, Prokopi M . Plasma microRNA profiling reveals loss of endothelial miR-126 and other microRNAs in type 2 diabetes. Circ Res. 2010; 107(6):810-7. DOI: 10.1161/CIRCRESAHA.110.226357. View

11.

Dooley J, Garcia-Perez J, Sreenivasan J, Schlenner S, Vangoitsenhoven R, Papadopoulou A . The microRNA-29 Family Dictates the Balance Between Homeostatic and Pathological Glucose Handling in Diabetes and Obesity. Diabetes. 2015; 65(1):53-61. PMC: 4876765. DOI: 10.2337/db15-0770. View

12.

Zhang J, Wu L, Chen J, Lin S, Cai D, Chen C . Downregulation of MicroRNA 29a/b exacerbated diabetic retinopathy by impairing the function of Müller cells via Forkhead box protein O4. Diab Vasc Dis Res. 2018; 15(3):214-222. DOI: 10.1177/1479164118756239. View

13.

Zhang X, Gong X, Han S, Zhang Y . MiR-29b protects dorsal root ganglia neurons from diabetic rat. Cell Biochem Biophys. 2014; 70(2):1105-11. DOI: 10.1007/s12013-014-0029-y. View

14.

Liang Z, Gao K, Wang Y, Liu Z, Tian L, Yang X . RNA sequencing identified specific circulating miRNA biomarkers for early detection of diabetes retinopathy. Am J Physiol Endocrinol Metab. 2018; 315(3):E374-E385. DOI: 10.1152/ajpendo.00021.2018. View

15.

Wilkinson C, Ferris 3rd F, Klein R, Lee P, Agardh C, Davis M . Proposed international clinical diabetic retinopathy and diabetic macular edema disease severity scales. Ophthalmology. 2003; 110(9):1677-82. DOI: 10.1016/S0161-6420(03)00475-5. View

16.

Zhang J, Chen M, Chen J, Lin S, Cai D, Chen C . Long non-coding RNA MIAT acts as a biomarker in diabetic retinopathy by absorbing and regulating cell apoptosis. Biosci Rep. 2017; 37(2). PMC: 5408653. DOI: 10.1042/BSR20170036. View

17.

Khullar M, Cheema B, Raut S . Emerging Evidence of Epigenetic Modifications in Vascular Complication of Diabetes. Front Endocrinol (Lausanne). 2017; 8:237. PMC: 5649155. DOI: 10.3389/fendo.2017.00237. View

18.

Sebastiani G, Nigi L, Grieco G, Mancarella F, Ventriglia G, Dotta F . Circulating microRNAs and diabetes mellitus: a novel tool for disease prediction, diagnosis, and staging?. J Endocrinol Invest. 2017; 40(6):591-610. DOI: 10.1007/s40618-017-0611-4. View

19.

Boucas A, Brondani L, Souza B, Lemos N, de Oliveira F, Canani L . The A allele of the rs1990760 polymorphism in the IFIH1 gene is associated with protection for arterial hypertension in type 1 diabetic patients and with expression of this gene in human mononuclear cells. PLoS One. 2014; 8(12):e83451. PMC: 3873949. DOI: 10.1371/journal.pone.0083451. View

20.

Mirra P, Nigro C, Prevenzano I, Leone A, Raciti G, Formisano P . The Destiny of Glucose from a MicroRNA Perspective. Front Endocrinol (Lausanne). 2018; 9:46. PMC: 5834423. DOI: 10.3389/fendo.2018.00046. View